Caitong International Asset Management’s Eton Pharmaceutcials ETON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30.5K Buy
842
+818
+3,408% +$24K ﹤0.01% 856
2026
Q1
$592 Sell
24
-2,915
-99% -$51K ﹤0.01% 1585
2025
Q4
$49.7K Buy
+2,939
New +$51.7K 0.01% 703
2025
Q3
Sell
-433
Closed -$6.17K 2117
2025
Q2
$6.17K Buy
433
+356
+462% +$5.63K ﹤0.01% 932
2025
Q1
$999 Buy
+77
New +$1.16K ﹤0.01% 1574

Other funds holding ETON

Caitong International Asset Management's ETON Position: Q2 2026 in Review

Caitong International Asset Management increased its Eton Pharmaceutcials (ETON) stake by 3,408% in Q2 2026, buying an estimated $24K and bringing the position to 842 shares worth $30.5K. The position accounts for ﹤0.01% of the portfolio, ranked #856.

Caitong International Asset Management first reported a position in ETON in Q1 2025 and has held it in 5 quarters since. The position peaked at $49.7K in Q4 2025. 59 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • Caitong International Asset Management held 842 shares of Eton Pharmaceutcials worth $30.5K as of Q2 2026.
  • Caitong International Asset Management bought 818 Eton Pharmaceutcials shares in Q2 2026, an estimated $24K.
  • Eton Pharmaceutcials made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #856 holding.
  • Caitong International Asset Management first reported a position in Eton Pharmaceutcials in Q1 2025 and has held it in 5 quarters since.
  • Caitong International Asset Management's Eton Pharmaceutcials position peaked at $49.7K in Q4 2025.
  • 59 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.